Report Detail
Global Human Micobiome Market Size, Status and Forecast 2019-2025
- RnM3041055 |
- 28 February, 2019 |
- Global |
- 108 Pages |
- QYResearch |
- Other
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
In 2018, the global Human Micobiome market size was 170 million US$ and it is expected to reach 820 million US$ by the end of 2025, with a CAGR of 21.7% during 2019-2025.
This report focuses on the global Human Micobiome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Micobiome development in United States, Europe and China.
The key players covered in this study
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Market segment by Type, the product can be split into
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Other
Market segment by Application, split into
Treatment
Diagnosis
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Human Micobiome status, future forecast, growth opportunity, key market and key players.
To present the Human Micobiome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human Micobiome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Human Micobiome Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Gastrointestinal Tract Human Micobiome
- 1.4.3 Urogenital Tract Human Micobiome
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Human Micobiome Market Share by Application (2014-2025)
- 1.5.2 Treatment
- 1.5.3 Diagnosis
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Human Micobiome Market Size
- 2.2 Human Micobiome Growth Trends by Regions
- 2.2.1 Human Micobiome Market Size by Regions (2014-2025)
- 2.2.2 Human Micobiome Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Human Micobiome Market Size by Manufacturers
- 3.1.1 Global Human Micobiome Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Human Micobiome Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Human Micobiome Market Concentration Ratio (CR5 and HHI)
- 3.2 Human Micobiome Key Players Head office and Area Served
- 3.3 Key Players Human Micobiome Product/Solution/Service
- 3.4 Date of Enter into Human Micobiome Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Human Micobiome Market Size by Type (2014-2019)
- 4.2 Global Human Micobiome Market Size by Application (2014-2019)
5 United States
- 5.1 United States Human Micobiome Market Size (2014-2019)
- 5.2 Human Micobiome Key Players in United States
- 5.3 United States Human Micobiome Market Size by Type
- 5.4 United States Human Micobiome Market Size by Application
6 Europe
- 6.1 Europe Human Micobiome Market Size (2014-2019)
- 6.2 Human Micobiome Key Players in Europe
- 6.3 Europe Human Micobiome Market Size by Type
- 6.4 Europe Human Micobiome Market Size by Application
7 China
- 7.1 China Human Micobiome Market Size (2014-2019)
- 7.2 Human Micobiome Key Players in China
- 7.3 China Human Micobiome Market Size by Type
- 7.4 China Human Micobiome Market Size by Application
8 Japan
- 8.1 Japan Human Micobiome Market Size (2014-2019)
- 8.2 Human Micobiome Key Players in Japan
- 8.3 Japan Human Micobiome Market Size by Type
- 8.4 Japan Human Micobiome Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Human Micobiome Market Size (2014-2019)
- 9.2 Human Micobiome Key Players in Southeast Asia
- 9.3 Southeast Asia Human Micobiome Market Size by Type
- 9.4 Southeast Asia Human Micobiome Market Size by Application
10 India
- 10.1 India Human Micobiome Market Size (2014-2019)
- 10.2 Human Micobiome Key Players in India
- 10.3 India Human Micobiome Market Size by Type
- 10.4 India Human Micobiome Market Size by Application
11 Central & South America
- 11.1 Central & South America Human Micobiome Market Size (2014-2019)
- 11.2 Human Micobiome Key Players in Central & South America
- 11.3 Central & South America Human Micobiome Market Size by Type
- 11.4 Central & South America Human Micobiome Market Size by Application
12 International Players Profiles
- 12.1 Vedanta
- 12.1.1 Vedanta Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Human Micobiome Introduction
- 12.1.4 Vedanta Revenue in Human Micobiome Business (2014-2019)
- 12.1.5 Vedanta Recent Development
- 12.2 Seres Therapeutics
- 12.2.1 Seres Therapeutics Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Human Micobiome Introduction
- 12.2.4 Seres Therapeutics Revenue in Human Micobiome Business (2014-2019)
- 12.2.5 Seres Therapeutics Recent Development
- 12.3 Second Genome
- 12.3.1 Second Genome Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Human Micobiome Introduction
- 12.3.4 Second Genome Revenue in Human Micobiome Business (2014-2019)
- 12.3.5 Second Genome Recent Development
- 12.4 Rebiotix
- 12.4.1 Rebiotix Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Human Micobiome Introduction
- 12.4.4 Rebiotix Revenue in Human Micobiome Business (2014-2019)
- 12.4.5 Rebiotix Recent Development
- 12.5 ActoGeniX
- 12.5.1 ActoGeniX Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Human Micobiome Introduction
- 12.5.4 ActoGeniX Revenue in Human Micobiome Business (2014-2019)
- 12.5.5 ActoGeniX Recent Development
- 12.6 Enterome BioScience
- 12.6.1 Enterome BioScience Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Human Micobiome Introduction
- 12.6.4 Enterome BioScience Revenue in Human Micobiome Business (2014-2019)
- 12.6.5 Enterome BioScience Recent Development
- 12.7 AvidBiotics
- 12.7.1 AvidBiotics Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Human Micobiome Introduction
- 12.7.4 AvidBiotics Revenue in Human Micobiome Business (2014-2019)
- 12.7.5 AvidBiotics Recent Development
- 12.8 4D Pharma Research Ltd
- 12.8.1 4D Pharma Research Ltd Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Human Micobiome Introduction
- 12.8.4 4D Pharma Research Ltd Revenue in Human Micobiome Business (2014-2019)
- 12.8.5 4D Pharma Research Ltd Recent Development
- 12.9 Enterologics
- 12.9.1 Enterologics Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Human Micobiome Introduction
- 12.9.4 Enterologics Revenue in Human Micobiome Business (2014-2019)
- 12.9.5 Enterologics Recent Development
- 12.10 Metabogen
- 12.10.1 Metabogen Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Human Micobiome Introduction
- 12.10.4 Metabogen Revenue in Human Micobiome Business (2014-2019)
- 12.10.5 Metabogen Recent Development
- 12.11 Metabiomics
- 12.12 Ritter Pharmaceuticals
- 12.13 Osel
- 12.14 Symberix
- 12.15 Miomics
- 12.16 Symbiotix Biotherapies
- 12.17 MicroBiome Therapeutics LLC
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Human Micobiome . Industry analysis & Market Report on Human Micobiome is a syndicated market report, published as Global Human Micobiome Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Human Micobiome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
